Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma

The phosphatidylinositol-3-kinase (PI3K)/Akt oncogenic pathway is critical in glioblastomas. Loss of PTEN, a negative regulator of the PI3K pathway or activated PI3K/Akt pathway that drive increased proliferation, survival, neovascularization, glycolysis, and invasion is found in 70%–80% of malignan...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Koul, Dimpy, Shen, Ruijun, Kim, Yong-Wan, Kondo, Yasuko, Lu, Yiling, Bankson, Jim, Ronen, Sabrina M., Kirkpatrick, D. Lynn, Powis, Garth, Yung, W. K. Alfred
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2010
Teme:
Basic and Translational Investigations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2940638/
https://ncbi.nlm.nih.gov/pubmed/20156803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nop058
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items